Oramed Pharmaceuticals, Inc. (ORMP)
3.65
+0.01
(+0.27%)
USD |
NASDAQ |
Jun 09, 16:00
3.51
-0.14
(-3.84%)
Pre-Market: 08:58
Oramed Pharmaceuticals SG&A Expense (Quarterly) : 2.065M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Viatris, Inc. | 928.80M |
| Pfizer Inc. | 2.961B |
| SIGA Technologies, Inc. | 4.673M |
| Bristol Myers Squibb Co. | 1.617B |
| ANI Pharmaceuticals, Inc. | 73.66M |